FAR1
Basic information
Region (hg38): 11:13668659-13732346
Previous symbols: [ "MLSTD2" ]
Links
Phenotypes
GenCC
Source:
- fatty acyl-CoA reductase 1 deficiency (Moderate), mode of inheritance: AR
- fatty acyl-CoA reductase 1 deficiency (Strong), mode of inheritance: AR
- fatty acyl-CoA reductase 1 deficiency (Supportive), mode of inheritance: AR
- hereditary spastic paraplegia 9A (Supportive), mode of inheritance: AD
- spastic paraparesis-cataracts-speech delay syndrome (Strong), mode of inheritance: AD
- fatty acyl-CoA reductase 1 upregulation (Moderate), mode of inheritance: AD
- fatty acyl-CoA reductase 1 deficiency (Moderate), mode of inheritance: AR
- fatty acyl-CoA reductase 1 deficiency (Definitive), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Cataracts, spastic paraparesis, and speech delay; Peroxisomal fatty acyl-CoA reductase 1 disorder | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Biochemical; Craniofacial; Neurologic; Ophthalmologic | 26220973; 33239752 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (355 variants)
- Inborn_genetic_diseases (36 variants)
- Fatty_acyl-CoA_reductase_1_deficiency (10 variants)
- CATARACTS,_SPASTIC_PARAPARESIS,_AND_SPEECH_DELAY (6 variants)
- FAR1-related_disorder (5 variants)
- not_specified (4 variants)
- CATARACTS,_SPASTIC_PARAPLEGIA,_AND_SPEECH_DELAY (3 variants)
- FAR1-related_neurodevelopmental_disorder (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the FAR1 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000032228.6. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 93 | 99 | ||||
| missense | 156 | 167 | ||||
| nonsense | 5 | |||||
| start loss | 1 | 1 | ||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 2 | |||||
| Total | 7 | 7 | 164 | 97 | 1 |
Highest pathogenic variant AF is 0.00000434331
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| FAR1 | protein_coding | protein_coding | ENST00000354817 | 11 | 63677 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.985 | 0.0150 | 125631 | 0 | 4 | 125635 | 0.0000159 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 3.30 | 124 | 279 | 0.444 | 0.0000145 | 3395 |
| Missense in Polyphen | 9 | 55.962 | 0.16082 | 714 | ||
| Synonymous | 0.534 | 89 | 95.6 | 0.931 | 0.00000496 | 958 |
| Loss of Function | 4.18 | 3 | 26.0 | 0.116 | 0.00000133 | 315 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.0000616 | 0.0000615 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.0000177 | 0.0000176 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.0000341 | 0.0000327 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Catalyzes the reduction of saturated and unsaturated C16 or C18 fatty acyl-CoA to fatty alcohols (PubMed:15220348, PubMed:24108123). It plays an essential role in the production of ether lipids/plasmalogens which synthesis requires fatty alcohols (PubMed:20071337, PubMed:24108123). In parallel, it is also required for wax monoesters production since fatty alcohols also constitute a substrate for their synthesis (By similarity). {ECO:0000250|UniProtKB:Q922J9, ECO:0000269|PubMed:15220348, ECO:0000269|PubMed:20071337, ECO:0000269|PubMed:24108123}.;
- Disease
- DISEASE: Peroxisomal fatty acyl-CoA reductase 1 disorder (PFCRD) [MIM:616154]: An autosomal recessive metabolic disorder clinically characterized by severe intellectual disability, early-onset epilepsy, microcephaly, congenital cataracts, growth retardation, and spasticity. {ECO:0000269|PubMed:25439727}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Peroxisome - Homo sapiens (human);miR-targeted genes in epithelium - TarBase;miR-targeted genes in lymphocytes - TarBase;miR-targeted genes in muscle cell - TarBase;Metabolism of lipids;Metabolism;Wax biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.107
Intolerance Scores
- loftool
- 0.345
- rvis_EVS
- -0.21
- rvis_percentile_EVS
- 38.58
Haploinsufficiency Scores
- pHI
- 0.430
- hipred
- Y
- hipred_score
- 0.685
- ghis
- 0.581
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- H
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.843
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Far1
- Phenotype
Gene ontology
- Biological process
- ether lipid biosynthetic process;wax biosynthetic process;long-chain fatty-acyl-CoA metabolic process;glycerophospholipid biosynthetic process;oxidation-reduction process
- Cellular component
- peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;peroxisomal matrix
- Molecular function
- oxidoreductase activity;fatty-acyl-CoA reductase (alcohol-forming) activity;alcohol-forming fatty acyl-CoA reductase activity